Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo | |
Jia, Xiaoqing; Cheng, Jingyi; Shen, Zhenzhou; Shao, Zhimin; Liu, Guangyu | |
刊名 | MOLECULAR MEDICINE REPORTS
![]() |
2018 | |
卷号 | 17期号:4 |
关键词 | zoledronic acid hypoxia-inducible factor-1 fulvestrant breast cancer |
ISSN号 | 1791-2997 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3601082 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Jia, Xiaoqing,Cheng, Jingyi,Shen, Zhenzhou,et al. Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo[J]. MOLECULAR MEDICINE REPORTS,2018,17(4). |
APA | Jia, Xiaoqing,Cheng, Jingyi,Shen, Zhenzhou,Shao, Zhimin,&Liu, Guangyu.(2018).Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo.MOLECULAR MEDICINE REPORTS,17(4). |
MLA | Jia, Xiaoqing,et al."Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo".MOLECULAR MEDICINE REPORTS 17.4(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论